JASPER THERAPEUTICS, INC. Adjustments to Additional Paid in Capital, Other
JASPER THERAPEUTICS, INC. (JSPR) reported Adjustments to Additional Paid in Capital, Other of $96.93 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-11-09.
Discontinued › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2023-11-09
- JASPER THERAPEUTICS, INC. adjustments to additional paid in capital, other for the quarter ending 2023-03-31 was $96.93M.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month |
|---|---|
| 2023-03-31 | $96.93M 10-Q · filed 2023-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |